Eagle Pharmaceuticals adopts limited duration stockholder rights plan

Eagle Pharmaceuticals (EGRX) announced that its Board of Directors has adopted a limited duration stockholder rights agreement, effective immediately. The Company continues to experience a significant dislocation in the trading price of its common stock. The Rights Plan is intended to enable each of the Company’s stockholders to have the opportunity to realize the long-term value of their investment. The Rights Plan is intended to reduce the likelihood that any person or group gains control of the Company through open market accumulation of the Company’s common stock or other means and thereby potentially disadvantaging the interests of the Company’s stockholders without appropriately compensating all stockholders or without providing the Board sufficient time to make informed judgments and take actions that are in the best interests of the Company and its stockholders.